RYTM

RHYTHM PHARMACEUTICALS INC

RYTM·76243J105·US·Common Stock·Healthcare - Biotechnology-13D/G

RYTM (RHYTHM PHARMACEUTICALS INC) is held by 156 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($579.8M), BlackRock, Inc. ($542.4M), BAKER BROS. ADVISORS LP ($487.4M). Net institutional sentiment: Mixed.

156
Holders
(11 Elite)
$5.6B
Total Value
56% (160)
Consensus
90 buying - 70 selling
13F: Insider & Congress:
RYTMSmart Money Verdict
View all
Held by 156 funds
11 elite
Who's Trading
ActivistPAPerceptive Advisors LLC5.1%May 15, 2026
ActivistVAVanguard Capital Management5.0%Apr 30, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 27, 2026
InsiderGPGerman Christopher PaulSell $503KMar 4, 2026
InsiderSCSmith Hunter CSell $131KFeb 19, 2026
InsiderSCSmith Hunter CSell $171KFeb 19, 2026
InsiderSCSmith Hunter CSell $82KFeb 19, 2026
InsiderSCSmith Hunter CSell $60KFeb 19, 2026
InsiderSCSmith Hunter CSell $119KFeb 17, 2026
InsiderSCSmith Hunter CSell $20KFeb 17, 2026
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
6.7M$579.8M6.1%+179.00%
0
Decreased
6.2M(-1.0%)$542.4M0.0%+91.57%
0
Unchanged
5.6M$487.4M2.8%+354.67%
0
Decreased
3.4M(-1.8%)$297.2M0.2%+434.49%
0
New
3M$264.5M0.0%+21.04%
43
New
3M$258.1M0.0%+21.04%
43
Increased
2.3M(+3.3%)$197.6M0.0%+97.92%
32
Increased
2M(+7.3%)$170.9M0.0%+73.71%
33
Increased
1.9M(+52.2%)$167.8M0.7%+48.81%
60
Decreased
1.7M(-1.0%)$147M0.0%+80.79%
0
Increased
1.7M(+6.0%)$143.9M0.0%+85.95%
32
Increased
1.6M(+36.3%)$140.5M0.5%+86.91%
47
Increased
1.4M(+825.3%)$123.4M0.0%+19.32%
49
Increased
1.4M(+3.0%)$123.2M0.0%+253.85%
31
Increased
1.6M(+9.1%)$120M0.0%+33.94%
33
Decreased
1.3M(-20.8%)$111.9M0.2%+330.92%
0
Decreased
910,413(-2.1%)$97.5M0.0%+13.35%
0
Increased
1.1M(+13.2%)$97M0.0%+6.83%
34
Decreased
918,153(-18.5%)$79.9M0.0%+133.28%
0
Increased
846,801(+97.2%)$73.6M0.1%+10.29%
48

Showing 1-20 of 169

1 / 9

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used